Olusium Technologies in Advanced Research is part of Olusium (OL’TIAR), a company that prides itself on being a diverse and inclusive community of researchers, engineers, artists, scientists, designers, makers, doctors, and more. They are united by a passion for harnessing the latest technology to improve lives worldwide. Their focus is on innovation, excellence, and collaboration, aiming to solve complex problems and push the boundaries of what’s possible.One of their notable… Show more Olusium Technologies in Advanced Research is part of Olusium (OL’TIAR), a company that prides itself on being a diverse and inclusive community of researchers, engineers, artists, scientists, designers, makers, doctors, and more. They are united by a passion for harnessing the latest technology to improve lives worldwide. Their focus is on innovation, excellence, and collaboration, aiming to solve complex problems and push the boundaries of what’s possible.One of their notable advancements is in the field of cancer diagnosis. Olusium has developed a game-changing approach for early-stage, non-invasive, label-free, and cost-effective cancer diagnosis. This method eliminates the need for invasive biopsies and costly imaging tests, potentially improving cancer survival rates and reducing healthcare costs significantly.They also work on futuristic technologies like Brain Computer Interface (BCI), wireless power transfer, non-invasive disease diagnostics, and mind-controlled devices. These efforts are geared towards making future technologies accessible today, thereby providing comfort at all levels.Olusium’s commitment to technology and innovation is also directed towards creating a sustainable and greener world. They infuse technology into various sectors such as medical, transportation, waste management, farming, and healthcare, aiming to make the world a safer place for future generations. Show less

At the Cancer Institute (WIA) for Olusium in collaboration with CSIR-NIIST, I specialize in early-stage cancer detection and prognosis through advanced metabolomic studies. This research focuses on the most prevalent cancers, leveraging the power of artificial intelligence and embedded systems to analyze liquid biopsy samples in real-time. By integrating cutting-edge technology, we aim to uncover crucial cancer markers and improve early diagnosis and treatment outcomes.

Co-Principal Investigator II: At CSIR-NIIST for Olusium, with multiple clinical partners across various geographic locations, I am engaged in a pioneering research and development program focused on the early detection and prognosis of prevalent cancers, including but not limited to breast, larynx, and lung cancers, utilizing liquid-biopsy methodology in a multicentric mode across the Indian geography. Our research harnesses the power of translational engineering and advanced metabolomics to… Show more Co-Principal Investigator II: At CSIR-NIIST for Olusium, with multiple clinical partners across various geographic locations, I am engaged in a pioneering research and development program focused on the early detection and prognosis of prevalent cancers, including but not limited to breast, larynx, and lung cancers, utilizing liquid-biopsy methodology in a multicentric mode across the Indian geography. Our research harnesses the power of translational engineering and advanced metabolomics to identify potential cancer markers and metabolic changes, aiming to transform real-time, label-free, non-invasive, cost-effective cancer diagnostics and personalized medicine. My role involves guiding and working with a multidisciplinary team, integrating AI and machine learning to enhance diagnostic precision, and expanding our study to include biomarkers associated with cancer complications. I also oversee the analysis of nanomaterials characterization using AI. Show less

Co-Principal Investigator I: At CSIR-NIIST for Olusium, I serve as the co-principal investigator on a pioneering project dedicated to early-stage cancer detection and prognosis. This initiative employs a real-time approach targeting breast, laryngeal, and lung cancers. My work focuses on identifying potential cancer markers and metabolomic changes using translational engineering, aiming to enhance diagnostic accuracy and improve patient outcomes through advanced research and innovative… Show more Co-Principal Investigator I: At CSIR-NIIST for Olusium, I serve as the co-principal investigator on a pioneering project dedicated to early-stage cancer detection and prognosis. This initiative employs a real-time approach targeting breast, laryngeal, and lung cancers. My work focuses on identifying potential cancer markers and metabolomic changes using translational engineering, aiming to enhance diagnostic accuracy and improve patient outcomes through advanced research and innovative methodologies. Show less

Co-Principal Investigator I: At Government Medical College, as the Co-Principal Investigator via CSIR-NIIST, I am at the forefront of a groundbreaking research initiative titled "Early-stage Cancer Detection and Prognosis: A Real-time Approach for Breast, Larynx, and Lung Cancers." This project is hosted by CSIR-NIIST and Olusium, providing a robust foundation of support and collaboration. Our work focuses on the comprehensive analysis of patients' clinical records and Case Report Forms (CRF)… Show more Co-Principal Investigator I: At Government Medical College, as the Co-Principal Investigator via CSIR-NIIST, I am at the forefront of a groundbreaking research initiative titled "Early-stage Cancer Detection and Prognosis: A Real-time Approach for Breast, Larynx, and Lung Cancers." This project is hosted by CSIR-NIIST and Olusium, providing a robust foundation of support and collaboration. Our work focuses on the comprehensive analysis of patients' clinical records and Case Report Forms (CRF) to study the prevalence of these cancers. By integrating clinical radiology and histopathological records, we aim to translate these findings into actionable insights for early diagnosis and treatment planning.A central aspect of our research is the application of advanced Artificial Intelligence (AI) techniques. We are developing predictive models that leverage various AI methodologies, including deep learning and hybrid deep learning models, to enhance the accuracy and timeliness of cancer detection. These models analyze vast amounts of clinical data in real time, offering predictive insights that are crucial for early intervention and improved patient outcomes.Our multidisciplinary approach involves close collaboration with oncologists, radiologists, pathologists, and AI specialists. Together, we are dedicated to pushing the boundaries of medical research and clinical practice, aiming to make significant strides in the fight against cancer via the liquid biopsy approach. By integrating clinical expertise with cutting-edge AI technologies, our goal is to revolutionize early cancer detection and provide patients with timely, accurate, and life-saving prognostic information. Show less

Co-Principal Investigator II: At Government Medical College, Thiruvananthapuram for Olusium and CSIR-NIIST, I am engaged in a pioneering research and development program focused on the early detection and prognosis of prevalent cancers, including but not limited to breast, larynx, and lung cancers, utilizing liquid-biopsy methodology in a multicentric mode across the Indian geography. Our research harnesses the power of translational engineering and advanced metabolomics to identify potential… Show more Co-Principal Investigator II: At Government Medical College, Thiruvananthapuram for Olusium and CSIR-NIIST, I am engaged in a pioneering research and development program focused on the early detection and prognosis of prevalent cancers, including but not limited to breast, larynx, and lung cancers, utilizing liquid-biopsy methodology in a multicentric mode across the Indian geography. Our research harnesses the power of translational engineering and advanced metabolomics to identify potential cancer markers and metabolic changes, aiming to transform real-time, label-free, non-invasive, cost-effective cancer diagnostics and personalized medicine. My role involves guiding and working with a multidisciplinary team, integrating AI and machine learning to enhance diagnostic precision, and expanding our study to include biomarkers associated with cancer complications. I also oversee the analysis of nanomaterials characterization using AI. Show less

To validate and approve innovation and verify standards and plans.To be empanelled as Valuer, Loss Assessor in various financial institutions like Bank, Insurance companies etc.To be empanelled as Chartered Engineer in the Original Side of High Courts, Central. Excise and Customs and other similar govt concerns.Take over civil works from Municipal Corporation and similar govt bodies.

ADASIS (Advanced Driver Assistance Systems Interface Specifications)